Literature DB >> 15128379

Measures and models of nicotine dependence: positive reinforcement.

Steven Glautier1.   

Abstract

This paper addresses the problem of assessing nicotine dependence. The main objective is to develop theory-led suggestions for measures that will be relevant in the early phases of tobacco use, as well as in established smokers. Theoretical models of addiction falling into the general class of 'positive reinforcement theories' were identified and reviewed. From this review a number of drug effects and patterns of behaviour were distilled and categorized as either vulnerability or dependence indicators. A comparison of those features with the International Classification of Diseases (ICD-10) and Diagnostic and Statistical Manual (DSM-IV) diagnostic systems shows that neither system includes detailed assessment of vulnerability indicators. It is argued that measurement of vulnerability indicators, in addition to dependence indicators, may add to the predictive validity of assessments carried out in early career tobacco users, especially where there is limited evidence of established dependence. In addition, it is suggested that examination of measures that differentiate a subgroup of early career smokers termed 'rapid accelerators' may prove profitable and enable identification of the key parameters of nicotine reinforcement.

Entities:  

Mesh:

Year:  2004        PMID: 15128379     DOI: 10.1111/j.1360-0443.2004.00736.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  26 in total

Review 1.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

2.  Euphoriant effects of nicotine in smokers: fact or artifact?

Authors:  Reuven Dar; Rachel Kaplan; Lior Shaham; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2007-01-19       Impact factor: 4.530

3.  Light and intermittent smokers: background and perspective.

Authors:  Saul Shiffman
Journal:  Nicotine Tob Res       Date:  2009-02-26       Impact factor: 4.244

Review 4.  Light and intermittent cigarette smokers: a review (1989-2009).

Authors:  Chris R E Coggins; E Lenn Murrelle; Richard A Carchman; Christian Heidbreder
Journal:  Psychopharmacology (Berl)       Date:  2009-10-03       Impact factor: 4.530

5.  Nicotine dependence, "background" and cue-induced craving and smoking in the laboratory.

Authors:  Michael S Dunbar; Saul Shiffman; Thomas R Kirchner; Hilary A Tindle; Sarah M Scholl
Journal:  Drug Alcohol Depend       Date:  2014-06-23       Impact factor: 4.492

Review 6.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

7.  Nicotine flux: a potentially important tool for regulating electronic cigarettes.

Authors:  Thomas Eissenberg; Alan Shihadeh
Journal:  Nicotine Tob Res       Date:  2014-10-19       Impact factor: 4.244

8.  "I cannot live without my vape": Electronic cigarette user-identified indicators of vaping dependence.

Authors:  Eric K Soule; Joseph G L Lee; Kathleen L Egan; Kendall M Bode; Abigail C Desrosiers; Mignonne C Guy; Alison Breland; Pebbles Fagan
Journal:  Drug Alcohol Depend       Date:  2020-02-05       Impact factor: 4.492

Review 9.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

10.  Young adult waterpipe smokers: Smoking behaviors and associated subjective and physiological effects.

Authors:  Kawkab Shishani; Donelle Howell; Sterling McPherson; John Roll
Journal:  Addict Behav       Date:  2014-03-12       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.